Denali Therapeutics (NASDAQ:DNLI) used an analyst call from the 2026 WORLD Symposium in San Diego to highlight new and ...
Shareholder/Analyst Call February 5, 2026 3:30 PM ESTCompany ParticipantsRyan Watts - Co-Founder, President, CEO ...
SCOTTSDALE, Ariz. (AP) — Chris Gotterup seems to have figured out TPC Scottsdale, giving him a chance to finally see the ...
Researchers revealed a Phorpiex-distributed phishing campaign using malicious LNK files to deploy Global Group ransomware ...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need ...
OpenClaw, formerly Moltbot, has burst into the mainstream. Here’s everything you need to know about the viral AI agent now ...
Microsoft has given up on its VR/AR efforts in Windows long ago, with one key piece still standing in Windows 10 and 11.
BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...
The practical utility of CISA's KEV ransomware updates for defenders has been questioned because they are made without public notification.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results